Skip to main content
OpenTrials
Completed

NCT Number: NCT02544542

Clinical Trial of a New Rectum Cooling System on Patients of Hypoxic-ischemic Brain Damage

This study will try to evaluate the effectiveness and safety of a new method for achieving mild hypothermia, i.e.,mild hypothermia therapy through rectum. Half of participants will be treated by the widely-used hyper-hypothermia blanket method, while the other half will be treated by the investigators' new method.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400014, China

About this study

Mild hypothermia therapy has been proved to be beneficial to patients with severe traumatic brain injury. Currently a variety of cooling methods can achieve mild hypothermia,the hyper-hypothermia blanket being the most widely-used one.

Hyper-hypothermia blanket is a waterbed mattress connected to a thermostat-controlled water tank. Water is cooled in the tank and recycled between the tank and the mattress so that the patients sleeping on the mattress can be stably cooled. The operation is basically program-controlled ,but the whole system is quite expensive.

The investigators came up with a new cooling system which is very simple and accessible. A condom inserted with two 10# gastric tube and one 6# gastric tube and ringed with a rubber band is inserted into the patient's rectum, and ice-cold saline is pumped in through one 10# gastric tube and drained out from the other 10# gastric tube, the 6# gastric tube connected to the pressure monitor. Cooling rate is controlled by the flow speed of cold saline. The investigators will evaluate the effectiveness and safety of this new method for achieving mild hypothermia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Neonatal HIE
  • After cardiopulmonary resuscitation (CPR)
  • Severe craniocerebral injury (GCS < 8)
  • Acute central nervous system infection and severe brain edema or lasting convulsion
  • Severe cerebral edema caused by various metabolic factors

Exclusion criteria

  • End-stage heart failure
  • Uncorrected serious cardiovascular dysfunction
  • Active intracranial hemorrhage not under control
  • Platelet count < 50 * 10^9 / L

Treatment and study plan

Rectum cooling system

Device

Hyper-hypothermia blanket

Device

Primary outcomes

  1. Rate of Cooling

    Time frame: 4 hours

    The body temperature is measured every 15 minutes until the target temperature(33-35℃)is reached.

  2. Body Temperature Fluctuations in Maintenance Phase

    Time frame: 12 hours

    During the maintenance phase,the body temperature is measured every 15 minutes.

  3. Rate of Rewarming

    Time frame: 24 to 48 hours

    The body temperature is measured every 15 minutes until it rises to 36.5℃.

Secondary outcomes

  1. Incidence of Complications

    Time frame: 24 to 72 hours

    Any occurence of shiver,arrhythmia and coagulation abnormalities during the therapy.

  2. Fecal Occult Blood Testing Results Before and After the Therapy

    Time frame: Within 24 hours before the therapy and 48 to 72 hours after the therapy

Sponsors and collaborators

Lead sponsor

Children's Hospital of Chongqing Medical University

Other

Collaborators

  • Chongqing Science and Technology Commission

Registry information

Official study title

A Comparative Clinical Trial of a New Rectum Cooling System Versus Temperature-adjusting Blanket on Patients of Hypoxic-ischemic Brain Damage

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Sep 9, 2015
Registry last updated
Feb 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.